Key result
National age-adjusted heart failure mortality rates show no significant change from 2018 to 2023.
Why the study?
Contemporary evidence on heart failure mortality as the underlying cause of death remains fragmented across demographic groups and urbanization levels in the US from 2018 to 2023.
Cross-Sectional (n=512,960)
Yes
Despite the COVID-19 pandemic, overall national heart failure underlying mortality rates in the US remained statistically stable from 2018 to 2023, though significant disparities persist across demographic groups and urbanization levels.
Background: Contemporary evidence on heart failure (HF) recorded as the underlying cause of death remains fragmented across demographic groups and levels of urbanization.The 2018-2023 interval includes two years before the emergence of COVID-19 (2018COVID-19 ( -2019) ) and four years after its emergence (2020-2023).Objective: We aim to characterize the national underlying cause of HF mortality among US adults aged 45 years or older from 2018 through 2023; describe differences by sex, age, race, and Hispanic origin; and quantify changes in absolute death counts across the six National Center for Health Statistics (NCHS) urbanization categories.Hypothesis: We hypothesized that the national age-adjusted HF mortality rate would increase and that demographic differences and variation in geographic death counts would persist.Methods: This retrospective, population-based, serial cross-sectional study used Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) Underlying Cause of Death data (International Classification of Diseases, 10th Revision (ICD-10) I50).Age-adjusted mortality rates (AAMRs) per 100,000 were evaluated overall and across demographic groups; age-specific crude rates were used for age groups.Zero-joinpoint log-linear models estimated annual percent change (APC) for the overall population, race categories, and Hispanic-origin categories.Race and Hispanic origin were analyzed separately and may overlap.Urbanization analyses used death counts and percentage changes; urbanization-specific population-adjusted rates were not estimated.Deaths listing HF only as a contributing cause were outside the case definition.Results: There were 512,960 deaths with HF as the underlying cause; the aggregate AAMR was 59.6 per 100,000.No statistically significant overall temporal trend was detected (APC: 0.59%; 95% confidence interval (CI): -0.37 to 1.57; p = 0.227).Men had a higher aggregate AAMR than women (68.1 versus 53.0), and Black adults had the highest racial AAMR (70.9).Asian adults had a lower aggregate AAMR than White and Black adults (22.9);Hispanic adults had a lower AAMR than non-Hispanic adults (35.2 versus 61.9).In their respective analyses, Asian and Hispanic groups had increasing trends at the nominal 0.05 significance level (APC: 1.30%, p = 0.047, and 1.96%, p = 0.030, respectively).Age-specific mortality increased sharply with age.Death counts increased across all six urbanization categories, most in Medium Metro counties (+11.0%).Conclusions: No statistically significant national trend was detected during 2018-2023, while descriptive demographic differences and nominally significant increases in the Asian race and Hispanic-origin analyses were observed.These separate analyses do not establish differences between subgroup slopes or narrowing mortality gaps.Geographic findings describe absolute burden, not population-adjusted risk.The results concern HF as the underlying cause and do not measure total HF-associated mortality.
No takes yet. Share an insight, caveat, or question.
Sánchez et al. (2026) conducted a cross-sectional in Heart Failure Mortality (n=512,960). Time period (2018-2023) was evaluated on Annual percent change in overall age-adjusted heart failure mortality rate (APC 0.59%, 95% CI -0.37 to 1.57, p=0.227). Between 2018 and 2023, the national age-adjusted heart failure mortality rate showed no statistically significant overall temporal trend (APC 0.59%; 95% CI -0.37 to 1.57; p=0.227).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: